RxDoctor Payments Data

Rebecca Grinsell

Primary Care · Richmond, VANPI 1912477043

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Kyowa Kirin, Inc. at 36.7% of the total. Reporting peaked in 2022 at $8,163 and has fallen 95.4% since, to $376 in 2025. Among primary care clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,420in general payments, 2019–2025

Across 184 payments — averaging $67.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kyowa Kirin, Inc.$5K
  • Biohaven Pharmaceutical Holding Company Ltd.$3K
  • Ascensia Diabetes Care US Inc.$1K
  • AbbVie$607
  • Biohaven Pharmaceuticals, Inc.$324
  • Novartis$303
  • plus $2K from 27 others
$280in research payments, 2019–2025

Across 1 payment — averaging $280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$280

What the payments were for

  • Consulting fees$1,42011%
  • Speaking & faculty fees$6,73454%
  • Travel & lodging$7806%
  • Food & beverage$3,48628%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,420 in reported general payments places this provider in the 95th percentile of 142 primary care providers in Virginia.

See all primary care providers in Virginia

Medicare billing

Part B allowed, 2024
$24,374
Medicare patients
138
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Primidone13$536
Memantine Hcl11$421
Gabapentin14$233

Paid to pharmacies, not to this prescriber.

Other primary care in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →